Ileje Inelo Ukwubile

Dr. Ileje Inelo Ukwubile

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2025 in Neuroglia
Verified
Journal Article
Open access
PDF file
OIOlayemi Kafilat Ijomone
Olayemi Kafilat Ijomone
IUIleje Inelo Ukwubile
Ileje Inelo Ukwubile
OAOluoma Vivian Aneke
Oluoma Vivian Aneke
TOTobiloba S Olajide
Tobiloba S Olajide
HIHappiness Ochi Inyang
Happiness Ochi Inyang
OIOmamuyovwi Ijomone
Omamuyovwi Ijomone
Overexposure of humans to heavy metals and essential metals poses a significant risk for the development of neurological and neurodevelopmental disorders. The mechanisms through which these metals exert their effects include the generation of reactive oxygen species, mitochondrial dysfunction, activation of inflammatory pathways, and disruption of cellular signaling. The function of glial cells in brain development and in the maintenance of homeostasis cannot be overlooked. The glial cells are particularly susceptible to metal-induced neurotoxicity. Accumulation of metals in the brain promotes microglial activation, triggering inflammatory responses that can coincide with other mechanisms of neurotoxicity, inducing alteration in synaptic transmission, cognitive deficit, and neuronal damage. In this review, we highlighted the role of glial dysfunction in some selected neurodegenerative diseases and neurodevelopmental disorders. We further dive into how exposure to metals such as nickel, manganese, methyl mercury, cadmium, iron, arsenic, and lead affect the functions of the microglia, astrocytes, and oligodendrocytes and the mechanisms through which they exert the effects on the brain in relation to some selected neurodegenerative diseases and neurodevelopmental disorders. Potential therapeutic interventions such as the use of new and improved chelating agents and antioxidant therapies might be a significant approach to alleviating these metal-induced glial perturbations.

1 September 2020 in Basic and Clinical Neuroscience Journal
Verified
Journal Article
Open access
PDF file
GOGabriel Olaiya Omotoso
Gabriel Olaiya Omotoso
LALeviticus Oghenevurinrin Arietarhire
Leviticus Oghenevurinrin Arietarhire
IUIleje Inelo Ukwubile
Ileje Inelo Ukwubile
IGIsmail Temitayo Gbadamosi
Ismail Temitayo Gbadamosi
Introduction: This study aimed at assessing the protective mechanisms of Kolaviron (KV) on the cerebellum in a rat model of demyelination. Methods: Twenty-eight male Wistar rats were used in the present study. They were randomly divided into 4 groups of 7 rats. Group A (control) received corn oil (0.5 mL/kg/d); group B received 0.2% Cuprizone (CPZ); group C was treated with 200 mg/kg/d of KV, and group D received 0.2% CPZ and 200 mg/kg/d KV for 6 weeks. CPZ powder was mixed with the regular diet while KV was dissolved in corn oil and administered orally. A behavioral test was conducted at the termination of the experiment. Thereafter, the animals were sacrificed and their brains were removed with the excision of the cerebellum. A part of the cerebelli underwent tissue processing with a series of 5 µm thick sections cut from paraffin blocks for histological and immunohistochemical assessment. Besides, the remaining cerebellar tissues were homogenized for the spectrophotometric assays of Oxidative Stress (OS) parameters. Results: The current research findings revealed minimal weight gain following CPZ treatment, but significant weight increase in KV-treated rats. CPZ treatment was associated with a reduction in the number of the line crossed, rearing frequency, rearing duration, center square entry, and center square duration; however, it increased the freezing time, i.e. significantly reversed in the KV-treated animals. Oxidative markers, such as Superoxide Dismutase (SOD) and GPx were reduced in CPZ-treated rats with elevated MDA levels. However, these data were significantly reversed by the co-administration of CPZ and KV. At the tissue level, the cerebellar cortex was characterized by poorly defined layers, cryptic granules, as well as chromatolysis and pyknotic Purkinje cells with the evidence of hypertrophic astrogliosis. Conclusion: CPZ treatment significantly depressed locomotor and exploratory activities. Furthermore, it increased OS and cerebellar toxicity. However, KV intervention significantly enhanced behavioral functions and ameliorated CPZ-induced cerebellar degeneration. Moreover, it considerably regulated OS markers in the cerebellum of the rat model of demyelinating diseases.

1 January 2026 in The Journal of Anatomical Sciences
Verified
Journal Article
Open access
MDMoyosoluwa M. Dada
Moyosoluwa M. Dada
LALeviticus O. Arietarhire
Leviticus O. Arietarhire
JEJoseph I. Enya
Joseph I. Enya
IUIleje Inelo Ukwubile
Ileje Inelo Ukwubile
TAToluwanimi O. Afolabi
Toluwanimi O. Afolabi
KAKehinde O. Adeniji
Kehinde O. Adeniji
Schizophrenia and related psychiatric disorders are often characterized by hippocampal dysfunction and demyelination. Cuprizone (CPZ), a copper chelator, is commonly used to induce neurotoxicity and oxidative stress in rodent models to mimic these dysfunctions. This study investigated the neuroprotective potential of Kolaviron (Kv), a biflavonoid complex from Garcinia kola, against CPZ-induced hippocampal damage. Twenty-eight male Wistar rats were divided into four groups: Control (corn oil), CPZ (0.2% diet), Kv (200 mg/kg), and Kv+CPZ. Following 42 days of treatment, hippocampal health was assessed through biochemical assays for oxidative stress (SOD, GPx, and MDA), and histological evaluation using H&E, Cresyl Fast Violet (Nissl profiling), and GFAP immunohistochemistry. The results show that CPZ administration significantly decreased antioxidant enzyme activities (SOD and GPx) and increased lipid peroxidation (MDA levels) in the hippocampus. Pyknotic changes and disorganized pyramidal neurons were evident in the CA1-CA3 regions, and significant chromatolysis. Furthermore, increased GFAP-positive reactive astrocytes were seen as a result of astrogliosis induced by CPZ. Conversely, concurrent administration of Kolaviron significantly mitigated these effects, restoring antioxidant levels, reducing MDA, and preserving the morphological integrity of pyramidal neurons and astrocytes. In conclusion, Kolaviron exhibits significant neuroprotective properties against cuprizone-induced hippocampal impairment. Its ability to suppress oxidative stress, maintain Nissl substance, and prevent reactive astrogliosis suggests that Kolaviron may be a viable therapeutic candidate for managing neurodegenerative and psychiatric disorders associated with hippocampal oxidative damage.

12 July 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
LALeviticus Oghenevurinrin ARIETARHIRE
Leviticus Oghenevurinrin ARIETARHIRE
AAAisha Iyabo Ayuba
Aisha Iyabo Ayuba
KKKeji- Salmat Temilola Keji-Taofik
Keji- Salmat Temilola Keji-Taofik
EIEvi Ndudi Imonikosaye
Evi Ndudi Imonikosaye
JEJoseph Igbo Enya
Joseph Igbo Enya
EOEzekiel Abiola Olugbogi
Ezekiel Abiola Olugbogi
The phenotypic manifestation of lead toxicity includes cognitive, learning, and memory decline which is associated with neuronal injuries and death and been a major challenge in public health especially in developing countries. Thus, we explore the prophylactic potentials of luteolin in prefrontal Pb intoxication. Thirty-six (36) male Wistar Rats were used for this research and di-vided into six (6) groups of six animals each and were treated orally as follows: Group 1-Normal saline (0.5ml daily for 14 days); Group 2- PbCl3 (50mg/kg of PbCl3 daily for 14 days); Group 3- luteolin (100mg/kg of LUT daily for 14 days); Group 4- luteolin and PbCl3 (50mg/kg PbCl3 and 100mg/kg LUT daily for 14 days); Group 5- PbCl3 then luteolin (50mg/kg of PbCl3 daily for 14 days followed by 100mg/kg of LUT daily for 14 days); Group 6- luteolin then PbCl3 (100mg/kg of LUT daily for 14days followed by 50mg/kg of PbCl3 daily for 14 days). We measured cerebral oxidative redox parameters, G6PDH, IL-6, acetylcholinesterase levels, and total protein profiles using ELISA and biochemical assay kits. We also examined cerebral morphology and the Nissl profile with H&E and toluidine blue staining techniques, as well as astrocytic morphology and synaptic integrity with anti-GFAP and anti-synaptophysin antibodies. As a result of Pb perturba-tion, luteolin treatment inhibits MDA, IL-6, and AChE expression while increasing antioxidant enzyme activities (SOD, GPx) and G6PDH. Furthermore, luteolin has significant prophylactic po-tential against Pb-induced neuronal injuries and modulates astrocyte actions, preserving synap-tic integrity and thus improving cognition, learning, and memory. Taken together, our findings indicate that luteolin may be a promising candidate for managing and treating Pb neural intoxi-cation.